根分岐部病変治療の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Bifurcation Lesions Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：MRC2012B0120
• 出版社/出版日：GlobalInfoResearch / 2020年12月21日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、103ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートでは、根分岐部病変治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。根分岐部病変治療の種類別市場規模（Tステント、キュロット、クラッシュ、Vステント、Yステント、ジャイレッドバルーン）、用途別市場規模（冠状血管、末梢血管）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Medtronic、Cardinal Health、Abbott、Boston Scientific Corporation、Terumo Medical Corporation、Johnson& Johnson Services, Inc、Spectranetics、C. R. Bard, Inc.、
・地域別グローバル市場分析 2015年-2020年
・根分岐部病変治療の北米市場（アメリカ、カナダ、メキシコ）
・根分岐部病変治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア）
・根分岐部病変治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア）
・根分岐部病変治療の南米市場（ブラジル、アルゼンチン）
・根分岐部病変治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ）
・種類別分析：Tステント、キュロット、クラッシュ、Vステント、Yステント、ジャイレッドバルーン
・用途別分析：冠状血管、末梢血管
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Bifurcation Lesions Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Bifurcation Lesions Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Bifurcation Lesions Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Bifurcation Lesions Treatment market has been segmented into:
T Stent
Culotte
Crush
V Stent
Y Stent
Jailed Balloon

By Application, Bifurcation Lesions Treatment has been segmented into:
Coronary Vascular
Peripheral Vascular

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Bifurcation Lesions Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Bifurcation Lesions Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Bifurcation Lesions Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Bifurcation Lesions Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Bifurcation Lesions Treatment Market Share Analysis
Bifurcation Lesions Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Bifurcation Lesions Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Bifurcation Lesions Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Bifurcation Lesions Treatment are:
Medtronic
Cardinal Health
Abbott
Boston Scientific Corporation
Terumo Medical Corporation
Johnson& Johnson Services, Inc
Spectranetics
C. R. Bard, Inc.

レポート目次

Table of Contents

1 Bifurcation Lesions Treatment Market Overview
1.1 Product Overview and Scope of Bifurcation Lesions Treatment
1.2 Classification of Bifurcation Lesions Treatment by Type
1.2.1 Global Bifurcation Lesions Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Bifurcation Lesions Treatment Revenue Market Share by Type in 2019
1.2.3 T Stent
1.2.4 Culotte
1.2.5 Crush
1.2.6 V Stent
1.2.7 Y Stent
1.2.8 Jailed Balloon
1.3 Global Bifurcation Lesions Treatment Market by Application
1.3.1 Overview: Global Bifurcation Lesions Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Coronary Vascular
1.3.3 Peripheral Vascular
1.4 Global Bifurcation Lesions Treatment Market by Regions
1.4.1 Global Bifurcation Lesions Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Bifurcation Lesions Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Bifurcation Lesions Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Bifurcation Lesions Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bifurcation Lesions Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Bifurcation Lesions Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bifurcation Lesions Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Medtronic SWOT Analysis
2.1.4 Medtronic Product and Services
2.1.5 Medtronic Bifurcation Lesions Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cardinal Health
2.2.1 Cardinal Health Details
2.2.2 Cardinal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cardinal Health SWOT Analysis
2.2.4 Cardinal Health Product and Services
2.2.5 Cardinal Health Bifurcation Lesions Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott SWOT Analysis
2.3.4 Abbott Product and Services
2.3.5 Abbott Bifurcation Lesions Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boston Scientific Corporation
2.4.1 Boston Scientific Corporation Details
2.4.2 Boston Scientific Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boston Scientific Corporation SWOT Analysis
2.4.4 Boston Scientific Corporation Product and Services
2.4.5 Boston Scientific Corporation Bifurcation Lesions Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Terumo Medical Corporation
2.5.1 Terumo Medical Corporation Details
2.5.2 Terumo Medical Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Terumo Medical Corporation SWOT Analysis
2.5.4 Terumo Medical Corporation Product and Services
2.5.5 Terumo Medical Corporation Bifurcation Lesions Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson& Johnson Services, Inc
2.6.1 Johnson& Johnson Services, Inc Details
2.6.2 Johnson& Johnson Services, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson& Johnson Services, Inc SWOT Analysis
2.6.4 Johnson& Johnson Services, Inc Product and Services
2.6.5 Johnson& Johnson Services, Inc Bifurcation Lesions Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Spectranetics
2.7.1 Spectranetics Details
2.7.2 Spectranetics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Spectranetics SWOT Analysis
2.7.4 Spectranetics Product and Services
2.7.5 Spectranetics Bifurcation Lesions Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 C. R. Bard, Inc.
2.8.1 C. R. Bard, Inc. Details
2.8.2 C. R. Bard, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 C. R. Bard, Inc. SWOT Analysis
2.8.4 C. R. Bard, Inc. Product and Services
2.8.5 C. R. Bard, Inc. Bifurcation Lesions Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Bifurcation Lesions Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Bifurcation Lesions Treatment Players Market Share
3.2.2 Top 10 Bifurcation Lesions Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Bifurcation Lesions Treatment Revenue and Market Share by Regions
4.2 North America Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
5 North America Bifurcation Lesions Treatment Revenue by Countries
5.1 North America Bifurcation Lesions Treatment Revenue by Countries (2015-2020)
5.2 USA Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
6 Europe Bifurcation Lesions Treatment Revenue by Countries
6.1 Europe Bifurcation Lesions Treatment Revenue by Countries (2015-2020)
6.2 Germany Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
6.4 France Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Bifurcation Lesions Treatment Revenue by Countries
7.1 Asia-Pacific Bifurcation Lesions Treatment Revenue by Countries (2015-2020)
7.2 China Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
7.5 India Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
8 South America Bifurcation Lesions Treatment Revenue by Countries
8.1 South America Bifurcation Lesions Treatment Revenue by Countries (2015-2020)
8.2 Brazil Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Bifurcation Lesions Treatment by Countries
9.1 Middle East & Africa Bifurcation Lesions Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Bifurcation Lesions Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Bifurcation Lesions Treatment Market Forecast by Type (2019-2024)
10.3 T Stent Revenue Growth Rate (2015-2025)
10.4 Culotte Revenue Growth Rate (2015-2025)
10.5 Crush Revenue Growth Rate (2015-2025)
10.6 V Stent Revenue Growth Rate (2015-2025)
10.7 Y Stent Revenue Growth Rate (2015-2025)
10.8 Jailed Balloon Revenue Growth Rate (2015-2025)
11 Global Bifurcation Lesions Treatment Market Segment by Application
11.1 Global Bifurcation Lesions Treatment Revenue Market Share by Application (2015-2020)
11.2 Bifurcation Lesions Treatment Market Forecast by Application (2019-2024)
11.3 Coronary Vascular Revenue Growth (2015-2020)
11.4 Peripheral Vascular Revenue Growth (2015-2020)
12 Global Bifurcation Lesions Treatment Market Size Forecast (2021-2025)
12.1 Global Bifurcation Lesions Treatment Market Size Forecast (2021-2025)
12.2 Global Bifurcation Lesions Treatment Market Forecast by Regions (2021-2025)
12.3 North America Bifurcation Lesions Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Bifurcation Lesions Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Bifurcation Lesions Treatment Revenue Market Forecast (2021-2025)
12.6 South America Bifurcation Lesions Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Bifurcation Lesions Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Bifurcation Lesions Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Bifurcation Lesions Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Bifurcation Lesions Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Bifurcation Lesions Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Medtronic Corporate Information, Location and Competitors
Table 6. Medtronic Bifurcation Lesions Treatment Major Business
Table 7. Medtronic Bifurcation Lesions Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Medtronic SWOT Analysis
Table 9. Medtronic Bifurcation Lesions Treatment Product and Solutions
Table 10. Medtronic Bifurcation Lesions Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Cardinal Health Corporate Information, Location and Competitors
Table 12. Cardinal Health Bifurcation Lesions Treatment Major Business
Table 13. Cardinal Health Bifurcation Lesions Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Cardinal Health SWOT Analysis
Table 15. Cardinal Health Bifurcation Lesions Treatment Product and Solutions
Table 16. Cardinal Health Bifurcation Lesions Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Abbott Corporate Information, Location and Competitors
Table 18. Abbott Bifurcation Lesions Treatment Major Business
Table 19. Abbott Bifurcation Lesions Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Abbott SWOT Analysis
Table 21. Abbott Bifurcation Lesions Treatment Product and Solutions
Table 22. Abbott Bifurcation Lesions Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Boston Scientific Corporation Corporate Information, Location and Competitors
Table 24. Boston Scientific Corporation Bifurcation Lesions Treatment Major Business
Table 25. Boston Scientific Corporation Bifurcation Lesions Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Boston Scientific Corporation SWOT Analysis
Table 27. Boston Scientific Corporation Bifurcation Lesions Treatment Product and Solutions
Table 28. Boston Scientific Corporation Bifurcation Lesions Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Terumo Medical Corporation Corporate Information, Location and Competitors
Table 30. Terumo Medical Corporation Bifurcation Lesions Treatment Major Business
Table 31. Terumo Medical Corporation Bifurcation Lesions Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Terumo Medical Corporation SWOT Analysis
Table 33. Terumo Medical Corporation Bifurcation Lesions Treatment Product and Solutions
Table 34. Terumo Medical Corporation Bifurcation Lesions Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Johnson& Johnson Services, Inc Corporate Information, Location and Competitors
Table 36. Johnson& Johnson Services, Inc Bifurcation Lesions Treatment Major Business
Table 37. Johnson& Johnson Services, Inc Bifurcation Lesions Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Johnson& Johnson Services, Inc SWOT Analysis
Table 39. Johnson& Johnson Services, Inc Bifurcation Lesions Treatment Product and Solutions
Table 40. Johnson& Johnson Services, Inc Bifurcation Lesions Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Spectranetics Corporate Information, Location and Competitors
Table 42. Spectranetics Bifurcation Lesions Treatment Major Business
Table 43. Spectranetics Bifurcation Lesions Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Spectranetics SWOT Analysis
Table 45. Spectranetics Bifurcation Lesions Treatment Product and Solutions
Table 46. Spectranetics Bifurcation Lesions Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. C. R. Bard, Inc. Corporate Information, Location and Competitors
Table 48. C. R. Bard, Inc. Bifurcation Lesions Treatment Major Business
Table 49. C. R. Bard, Inc. Bifurcation Lesions Treatment Total Revenue (USD Million) (2017-2018)
Table 50. C. R. Bard, Inc. SWOT Analysis
Table 51. C. R. Bard, Inc. Bifurcation Lesions Treatment Product and Solutions
Table 52. C. R. Bard, Inc. Bifurcation Lesions Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Bifurcation Lesions Treatment Revenue (Million USD) by Players (2015-2020)
Table 54. Global Bifurcation Lesions Treatment Revenue Share by Players (2015-2020)
Table 55. Global Bifurcation Lesions Treatment Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Bifurcation Lesions Treatment Revenue Market Share by Regions (2015-2020)
Table 57. North America Bifurcation Lesions Treatment Revenue by Countries (2015-2020)
Table 58. North America Bifurcation Lesions Treatment Revenue Market Share by Countries (2015-2020)
Table 59. Europe Bifurcation Lesions Treatment Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Bifurcation Lesions Treatment Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Bifurcation Lesions Treatment Revenue by Countries (2015-2020)
Table 62. South America Bifurcation Lesions Treatment Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Bifurcation Lesions Treatment Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Bifurcation Lesions Treatment Revenue Market Share by Countries (2015-2020)
Table 65. Global Bifurcation Lesions Treatment Revenue (Million USD) by Type (2015-2020)
Table 66. Global Bifurcation Lesions Treatment Revenue Share by Type (2015-2020)
Table 67. Global Bifurcation Lesions Treatment Revenue Forecast by Type (2021-2025)
Table 68. Global Bifurcation Lesions Treatment Revenue by Application (2015-2020)
Table 69. Global Bifurcation Lesions Treatment Revenue Share by Application (2015-2020)
Table 70. Global Bifurcation Lesions Treatment Revenue Forecast by Application (2021-2025)
Table 71. Global Bifurcation Lesions Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Bifurcation Lesions Treatment Picture
Figure 2. Global Bifurcation Lesions Treatment Revenue Market Share by Type in 2019
Figure 3. T Stent Picture
Figure 4. Culotte Picture
Figure 5. Crush Picture
Figure 6. V Stent Picture
Figure 7. Y Stent Picture
Figure 8. Jailed Balloon Picture
Figure 9. Bifurcation Lesions Treatment Revenue Market Share by Application in 2019
Figure 10. Coronary Vascular Picture
Figure 11. Peripheral Vascular Picture
Figure 12. Global Bifurcation Lesions Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Bifurcation Lesions Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Bifurcation Lesions Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Bifurcation Lesions Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Bifurcation Lesions Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Bifurcation Lesions Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Bifurcation Lesions Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Bifurcation Lesions Treatment Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Bifurcation Lesions Treatment Revenue Market Share in 2019
Figure 21. Global Top 10 Players Bifurcation Lesions Treatment Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Bifurcation Lesions Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Bifurcation Lesions Treatment Revenue Market Share by Regions (2015-2020)
Figure 25. Global Bifurcation Lesions Treatment Revenue Market Share by Regions in 2018
Figure 26. North America Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Europe Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 29. South America Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 31. North America Bifurcation Lesions Treatment Revenue Market Share by Countries (2015-2020)
Figure 32. North America Bifurcation Lesions Treatment Revenue Market Share by Countries in 2019
Figure 33. USA Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Canada Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Europe Bifurcation Lesions Treatment Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Bifurcation Lesions Treatment Revenue Market Share by Countries in 2019
Figure 38. Germany Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 39. UK Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 40. France Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Russia Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Italy Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Bifurcation Lesions Treatment Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Bifurcation Lesions Treatment Revenue Market Share by Countries in 2019
Figure 45. China Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Japan Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Korea Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 48. India Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 50. South America Bifurcation Lesions Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. South America Bifurcation Lesions Treatment Revenue Market Share by Countries in 2019
Figure 52. Brazil Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Bifurcation Lesions Treatment Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Bifurcation Lesions Treatment Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 57. UAE Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Bifurcation Lesions Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Global Bifurcation Lesions Treatment Revenue Share by Type (2015-2020)
Figure 61. Global Bifurcation Lesions Treatment Revenue Share by Type in 2019
Figure 62. Global Bifurcation Lesions Treatment Market Share Forecast by Type (2021-2025)
Figure 63. Global T Stent Revenue Growth Rate (2015-2020)
Figure 64. Global Culotte Revenue Growth Rate (2015-2020)
Figure 65. Global Crush Revenue Growth Rate (2015-2020)
Figure 66. Global V Stent Revenue Growth Rate (2015-2020)
Figure 67. Global Y Stent Revenue Growth Rate (2015-2020)
Figure 68. Global Jailed Balloon Revenue Growth Rate (2015-2020)
Figure 69. Global Bifurcation Lesions Treatment Revenue Share by Application (2015-2020)
Figure 70. Global Bifurcation Lesions Treatment Revenue Share by Application in 2019
Figure 71. Global Bifurcation Lesions Treatment Market Share Forecast by Application (2021-2025)
Figure 72. Global Coronary Vascular Revenue Growth Rate (2015-2020)
Figure 73. Global Peripheral Vascular Revenue Growth Rate (2015-2020)
Figure 74. Global Bifurcation Lesions Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Bifurcation Lesions Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Bifurcation Lesions Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Bifurcation Lesions Treatment Revenue Market Forecast (2021-2025)
Figure 78. Europe Bifurcation Lesions Treatment Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Bifurcation Lesions Treatment Revenue Market Forecast (2021-2025)
Figure 80. South America Bifurcation Lesions Treatment Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Bifurcation Lesions Treatment Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

以下、関連資料のご紹介

分岐部病変治療の世界市場（～2026年）

Global Bifurcation Lesions Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11041 2020年11月25日 97Pages
当調査資料は分岐部病変治療のグローバル市場について調査・分析したレポートです。種類別（Tステント、キュロット、クラッシュ、Vステント、Yステント、ジェイルドバルーン）市場規模、用途別（冠状血管、末梢血管）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、...

分岐部病変の世界市場（～2026年）

Global Bifurcation Lesions Market Size, Status and Forecast 2020-2026
MRC2-11QY11040 2020年11月25日 95Pages
当調査資料は分岐部病変のグローバル市場について調査・分析したレポートです。種類別（ワンステント、ツーステント）市場規模、用途別（冠状血管、末梢血管）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、...

MSD治療の世界市場2020年：企業別、地域別、種類・用途別

Global MSD Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
MRC2012B0838 2020年12月24日 101Pages
本調査レポートでは、MSD治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。MSD治療の種類別市場規模（OTC、処方薬）、用途別市場規模（病院、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量...

クラッベ病治療の世界市場（～2026年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12467 2020年11月25日 94Pages
当調査資料はクラッベ病治療のグローバル市場について調査・分析したレポートです。種類別（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

筋骨格系障害治療の世界市場2020年：企業別、地域別、種類・用途別

Global Musculoskeletal Disorders Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
MRC2012B0842 2020年12月24日 101Pages
本調査レポートでは、筋骨格系障害治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。筋骨格系障害治療の種類別市場規模（OTC、処方薬）、用途別市場規模（病院、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、...

アレルギー性鼻炎治療の世界市場（～2026年）

Global Allergic Rhinitis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY13652 2020年11月30日 91Pages
当調査資料はアレルギー性鼻炎治療のグローバル市場について調査・分析したレポートです。種類別（抗ヒスタミン薬、鼻腔内コルチコステロイド、免疫療法、充血除去薬、その他）市場規模、用途別（季節性アレルギー性鼻炎、通年性アレルギー性鼻炎）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イ...

結節性痒疹治療の世界市場（～2026年）

Global Prurigo Nodularis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04403 2020年11月20日 97Pages
当調査資料は結節性痒疹治療のグローバル市場について調査・分析したレポートです。種類別（カプサイシンクリーム、抗ヒスタミン薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

尿路感染症治療の世界市場（～2026年）

Global Urinary Tract Infection Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04952 2020年11月20日 99Pages
当調査資料は尿路感染症治療のグローバル市場について調査・分析したレポートです。種類別（複雑なUTI、再発性の複雑なUTI、単純なUTI、神経因性膀胱感染症、その他）市場規模、用途別（病院薬局、婦人科および泌尿器科クリニック、ドラッグストア、小売薬局、オンラインドラッグストア）市場規模、地域別（北米、...

乳糖不耐症治療の世界市場（～2026年）

Global Lactose Intolerance Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12475 2020年11月25日 90Pages
当調査資料は乳糖不耐症治療のグローバル市場について調査・分析したレポートです。種類別（栄養補助食品、酵素ラクターゼサプリメント、その他）市場規模、用途別（病院・クリニック、在宅医療、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

変形性関節症治療の世界市場（～2026年）

Global Osteoarthritis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04111 2020年11月20日 98Pages
当調査資料は変形性関節症治療のグローバル市場について調査・分析したレポートです。種類別（薬物、支援機器）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリ...

分岐部病変治療の世界市場（～2026年） Market Analysis and Insights: Global Bifurcation Lesions Treatment Market The global Bifurcation Lesions Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Bifurcation Lesions Treatment Scope and Market Size Bif…
分岐部病変の世界市場（～2026年） A artery narrowing occuring adjacent to, and/or involving, the origin of a significant side branch. North America dominated the bifurcation lesions market in 2016. The region is expected to maintain its dominance during the forecast period. This can be attributed to local presence of major market pl…
頭蓋内アテローム性動脈硬化症治療の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Intracranial Atherosclerotic Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, …
軟骨無形成症治療の世界市場（～2026年） Market Analysis and Insights: Global Achondroplasia Treatment Market The global Achondroplasia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Achondroplasia Treatment Scope and Market Size Achondroplasia Tre…
クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…